Swiftsure International Inc.

Holmes Biopharma Inc.: Aktuelle Unternehmensinformationen und Umwandlung

Holmes Biopharma stellt ein neues Management vor

Holmes Biopharma, Inc.: $ 1.2 Million Dollar Contract Awarded

HOLMES BIOPHARMA – Eastern European Operation Awarded First Contract

Holmes Biopharma, Inc.: Strong Sales Start for 2008

Holmes Biopharma, Inc.: Launches International Media Campaign

Holmes Biopharma, Inc.: Highest Single Month In Sales To Date

Holmes Biopharma Inc.: Initiates Broker Relations Program

Holmes Biopharma, Inc. : Largest Single Contract to Date

Holmes Biopharma Inc. Financing and Year End Forecast

Holmes Biopharma Inc.: Holmes Biopharma returns to OTC Bulletin Board

Holmes Biopharma Inc. Reaches Profitability in Q3 – 2007

Holmes Biopharma: Awarded Contracts Reach $10.5 Million

Holmes Biopharma Omaha Phase 1 Clinic Expansion

Holmes Biopharma – TVA Productions to Launch National and International MediaBlitz

Holmes Biopharma : Commences European Operations

Holmes Biopharma is Selected as a Preferred Service Provider by a Major Pharmaceutical Company

Holmes Biopharma : Vorvertrag – Erwerb von Medikamenten

Holmes Biopharma : Letter Of Intent – Drug Acquisition

Holmes Biopharma, Inc.: Holmes Biopharma Appoints Associate Director of Clinical Operations

Holmes Biopharma – Sales Activity Reaches $7 Million

Holmes Biopharma, Inc.: Clinical Research Business Becomes Profitable

Holmes Biopharma – Sales Activity Reaches $6 Million – Omaha Expansion Planned.

Holmes Biopharma – Commences Data Management Business

Holmes Biopharma – Verkaufstätigkeit erreicht $5 Million

Holmes Biopharma, Inc.: Berichtigung der Meldung vom 6.02.2007

Holmes Biopharma – Positionierung des Unternehmens für Wachstum in der Zukunft und nachhaltig höheren Shareholder Value

Holmes Biopharma, Inc.: Contracts and Revenue continue to grow

Holmes Biopharma – Erwerb eines Labors zur Arzneimittelentwicklung

Holmes Biopharma, Inc.: Umwandlung der Reg S-Aktien